Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells
Clinical trial NCT03778346 · UNKNOWN
Trial details
- NCT number
- NCT03778346
- Sponsor
- The Sixth Affiliated Hospital of Wenzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2022-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.